2013
DOI: 10.1371/annotation/3306cc63-2aab-42b1-98c1-7507705fff98
|View full text |Cite
|
Sign up to set email alerts
|

Correction: Cyclopia Extracts Act as ERα Antagonists and ERβ Agonists, In Vitro and In Vivo

Abstract: Hormone replacement therapy associated risks, and the concomitant reluctance of usage, has instigated the search for new generations of estrogen analogues that would maintain estrogen benefits without associated risks. Furthermore, if these analogues display chemo-preventative properties in breast and endometrial tissues it would be of great value. Both the selective estrogen receptor modulators as well as the selective estrogen receptor subtype modulators have been proposed as estrogen analogues with improved… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(1 citation statement)
references
References 118 publications
0
1
0
Order By: Relevance
“…The estrogenic effects of PEs are primarily mediated via ERα and ERβ (with higher affinity for Erβ) and by acting as agonists, partial agonists, and antagonists [69]. For example, isoflavone affinity for ERβ isoforms is approximately five times higher than the affinity for ERα isoforms, in contrast to E 2 , in which the affinities to both receptor types are generally the same [70][71][72].…”
Section: Signaling Via Nuclear Receptorsmentioning
confidence: 99%
“…The estrogenic effects of PEs are primarily mediated via ERα and ERβ (with higher affinity for Erβ) and by acting as agonists, partial agonists, and antagonists [69]. For example, isoflavone affinity for ERβ isoforms is approximately five times higher than the affinity for ERα isoforms, in contrast to E 2 , in which the affinities to both receptor types are generally the same [70][71][72].…”
Section: Signaling Via Nuclear Receptorsmentioning
confidence: 99%